title: Combined timolol and pilocarpine vs pilocarpine alone and timolol alone in the treatment of glaucoma.
abstract: We compared the effects of pilocarpine 4% alone, timolol 0.5% alone, and a combination of timolol 0.5% and pilocarpine 4% in the treatment of glaucoma. We treated 43 patients with glaucoma using each drug and then with the combination of drugs for four weeks each. Only patients with a morning intraocular pressure of at least 24 mm Hg without treatment were included. The patients were examined, after one and four weeks of treatment with pilocarpine, timolol, or combined timolol 0.5% and pilocarpine 4%, before the morning dose and at two and five hours after it. At the end of the study, the mean reduction in intraocular pressure from baseline was 9.2 +/- 5.1 mm Hg (28.5% +/- 12.7%) with combined timolol 0.5% and pilocarpine 4%, 5.6 +/- 3.6 mm Hg (17.6% +/- 9.7%) with pilocarpine, and 7.5 +/- 5.0 mm Hg (21.2% +/- 12.6%) with timolol. Intraocular pressure was consistently lower with the combination treatment than with timolol or pilocarpine alone. We believe that this combined solution of timolol-pilocarpine is a valuable contribution to the treatment of open-angle glaucoma.
authors.affiliation: Department of Ophthalmology, Assaf Harofeh Medical Center, Zerifin, Israel.
authors.forename: D
authors.initials: D
authors.lastname: Zadok
authors.forename: O
authors.initials: O
authors.lastname: Geyer
authors.forename: J
authors.initials: J
authors.lastname: Zadok
authors.forename: M
authors.initials: M
authors.lastname: Lazar
authors.forename: D
authors.initials: D
authors.lastname: Krakowski
authors.forename: P
authors.initials: P
authors.lastname: Nemet
mesh_terms: D000287:Administration, Topical; D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure; D008297:Male; D009798:Ocular Hypertension / Q000188:drug therapy*; D009883:Ophthalmic Solutions; D010862:Pilocarpine / Q000008:administration & dosage* / Q000627:therapeutic use; D013999:Timolol / Q000008:administration & dosage* / Q000627:therapeutic use; D014065:Tonometry, Ocular
chemical_list: D009883:Ophthalmic Solutions; D010862:Pilocarpine; D013999:Timolol